We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+15.87%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$469M
AUM Growth
+$28.6M
Cap. Flow
-$1.78M
Cap. Flow %
-0.38%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$1.78M

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.26%
2 Healthcare 29.79%
3 Consumer Staples 17.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOR
1
DELISTED
QUESTCOR PHARMA INC
QCOR
$191M 40.81%
3,296,660
STAA icon
2
STAAR Surgical
STAA
$1.13B
$86.7M 18.5%
6,401,639
MNST icon
3
Monster Beverage
MNST
$87.7B
$84.1M 17.94%
19,309,632
-360,000
-2% -$1.78M
MNST icon
4
PUT
Monster Beverage
MNST
$87.7B
$52.3M 11.15%
12,000,000
-1,200,000
-9% -$5.92M
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$263M
$34.3M 7.32%
11,178,639
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
$18.6M 3.98%
817,029
SLTM
7
DELISTED
SOLTA MED INC (DE)
SLTM
$1.41M 0.3%
680,723

Similar funds

Broadwood Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Broadwood Capital held 7 positions worth $469M, up 6.5% from $440M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2013: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Broadwood Capital's biggest Q3 2013 reduction was Monster Beverage, cutting an estimated $1.78M.
  • Broadwood Capital's ten largest holdings make up 100% of its $469M portfolio in Q3 2013.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2013.
  • Broadwood Capital's portfolio value rose 6.5% quarter-over-quarter to $469M.

Based on Broadwood Capital's 13F filing for Q3 2013, filed 14 Nov 2013.